The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 17, 2026
Snapshot (as of Aug 17, 2026): Bayer AG (BAYRY) pays a $0.03 annual dividend, yielding 0.23% at $13.84/share. Next ex-dividend date 2026-04-28. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.23%
Annual Dividend: $0.03 per share
Payout Ratio: -7.5%
Ex-Dividend Date: 2026-04-28
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 32
Bayer AG dividend investors are looking at a company that spans prescription pharmaceuticals, consumer health products, and crop science across global markets. The current yield sits at 0.22%, with a trailing annual dividend rate of $0.0275 per share paid quarterly. The next ex-dividend date is April 28, 2026. BAYRY's low beta of 0.833 points to below-market price volatility, which appeals more to stability-focused investors than to those chasing income.
Bayer AG pays out -7.5% of earnings as dividends, a payout ratio classified as conservative (below 40%). A negative payout ratio reflects a period of reported losses rather than a structural dividend problem, and the $0.0275 annual rate is low enough that Bayer AG dividend safety is not under pressure from the payout level alone. The most significant data-supported risk is the long-term decline in per-share dividends, which has fallen sharply from $2.8951 in 2014 to $0.0311 in 2025, showing that BAYRY has cut its dividend before when business conditions deteriorated.
Bayer AG dividend history shows a CAGR of -18.9% per year from 2007 to 2025. Per-share dividends fell from $1.3592 at the start of the window to $0.0311 by 2025 (with 2026 partial at $0.0321). The largest annual increase in the window was 54.2% in 2008, but the data also contains multiple year-over-year declines exceeding 5%, and the overall direction has been sharply downward.
BAYRY is a low-yield stock with a dividend that has shrunk dramatically over the measured period, making it a poor fit for income-focused dividend investors. The current yield of 0.22% is classified as low (below 2%), and it sits far below the 5-year average yield of 2.56%, reflecting how much the per-share payment has contracted. Bayer AG operates across pharmaceuticals, consumer health, and crop science, giving it diversified revenue exposure, but that breadth has not translated into dividend growth. An investor in BAYRY gets a conservatively sized payout relative to current earnings, but accepts a dividend that has declined severely over time and offers minimal current income.
| Payment Date | Amount per Share |
|---|---|
| 2026-04-28 | $0.0321 |
| 2025-04-29 | $0.0311 |
| 2024-04-29 | $0.0294 |
| 2023-05-02 | $0.6602 |
| 2022-05-02 | $0.5258 |
| 2021-04-28 | $0.6041 |
| 2020-04-29 | $0.7626 |
| 2019-04-29 | $0.7823 |
| 2018-06-22 | $0.4162 |
| 2018-05-25 | $0.8131 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.0321 |
| 2025 | $0.0311 |
| 2024 | $0.0294 |
| 2023 | $0.6602 |
| 2022 | $0.5258 |
Project income from BAYRY with the BAYRY dividend calculator or track your full portfolio with the dividend tracker.